Procurement

NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025

  • NHS England

Procurement identifier (OCID): ocds-h6vhtk-04e273

Description

NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025<br/>CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 <br/>CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026

Notices

F03: Contract award notice

Notice identifier
2025/S 000-043951
Published
29 July 2025, 3:34pm

F02: Contract notice

Notice identifier
2025/S 000-005287
Published
17 February 2025, 9:56am